Indicated for: hyperprolactinemia
Route of administration: oral
Substance: cabergoline (dopamine agonist)
ATC: G02CB03 (Genito urinary system and sex hormones | Other gynecologicals | Prolactine inhibitors)
Cabergoline is a medication used for the treatment of hyperprolactinemia, a condition characterized by elevated prolactin levels in the blood, which can cause infertility, menstrual disorders, and other symptoms. It is a dopamine receptor agonist that works by inhibiting prolactin secretion from the pituitary gland.
The medication is taken orally, usually once or twice a week, as directed by a doctor. The dosage is adjusted based on prolactin levels and the patient's response to treatment.
Common side effects include nausea, dizziness, headache, fatigue, and constipation. In rare cases, more severe adverse effects such as cardiac disorders, pulmonary fibrosis, or severe allergic reactions may occur.
Cabergoline is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, regular monitoring is important to assess the effectiveness of the treatment and to detect potential adverse effects.
Price
Copayment
Patient
75.90 RON
37.95 RON
37.95 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
75.90 RON
75.90 RON
0.00 RON